Industry Research Reports
Home > Reports > Medical Devices & Consumables > Human Neuregulin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Human Neuregulin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 121 Pages
Report ld: 4618859
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human Neuregulin Market Size(US$)
CAGR 2025-2031
5%
Market Size,2031
USD 309
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 231 million
Market Forecast in 2031(Value)
US$ 309 million
CAGR
5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Human Neuregulin was estimated to be worth US$ 221 million in 2024 and is forecast to a readjusted size of US$ 309 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Recombinant human neuregulin is a class of EGF-like signaling molecules, which are a class of paracrine, autocrine and paracrine signaling polypeptides that mediate a variety of cellular functions in neurons and non-neural systems, including survival, proliferation and differentiation. NRGs participate in cell-cell crosstalk and play an important role in the development, maintenance and repair of organs such as the nervous system, heart and breast.
North American market for Human Neuregulin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Neuregulin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Human Neuregulin was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Human Neuregulin include BPS Bioscience, R&D Systems, Inc., YEASEN, Sinobiological, InVitria, Thermo Fisher Scientific Inc., Cell Guidance Systems LLC, Abcam Limited, ACROBiosystems, Proteintech Group, Inc, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Human Neuregulin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Neuregulin by region & country, by Type, and by Application.
The Human Neuregulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Neuregulin.
MARKET SEGMENTATION
By Company
- BPS Bioscience
- R&D Systems, Inc.
- YEASEN
- Sinobiological
- InVitria
- Thermo Fisher Scientific Inc.
- Cell Guidance Systems LLC
- Abcam Limited
- ACROBiosystems
- Proteintech Group, Inc
- BioLegend, Inc
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity < 97%
- Purity ≥ 97%
Segment by Application
- Laboratory
- University
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Neuregulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Neuregulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Neuregulin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Human Neuregulin Product Introduction
1.2 Global Human Neuregulin Market Size Forecast
1.2.1 Global Human Neuregulin Sales Value (2020-2031)
1.2.2 Global Human Neuregulin Sales Volume (2020-2031)
1.2.3 Global Human Neuregulin Sales Price (2020-2031)
1.3 Human Neuregulin Market Trends & Drivers
1.3.1 Human Neuregulin Industry Trends
1.3.2 Human Neuregulin Market Drivers & Opportunity
1.3.3 Human Neuregulin Market Challenges
1.3.4 Human Neuregulin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Neuregulin Players Revenue Ranking (2024)
2.2 Global Human Neuregulin Revenue by Company (2020-2025)
2.3 Global Human Neuregulin Players Sales Volume Ranking (2024)
2.4 Global Human Neuregulin Sales Volume by Company Players (2020-2025)
2.5 Global Human Neuregulin Average Price by Company (2020-2025)
2.6 Key Manufacturers Human Neuregulin Manufacturing Base and Headquarters
2.7 Key Manufacturers Human Neuregulin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human Neuregulin
2.9 Human Neuregulin Market Competitive Analysis
2.9.1 Human Neuregulin Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Neuregulin Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Neuregulin as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity < 97%
3.1.2 Purity ≥ 97%
3.2 Global Human Neuregulin Sales Value by Type
3.2.1 Global Human Neuregulin Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Human Neuregulin Sales Value, by Type (2020-2031)
3.2.3 Global Human Neuregulin Sales Value, by Type (%) (2020-2031)
3.3 Global Human Neuregulin Sales Volume by Type
3.3.1 Global Human Neuregulin Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Human Neuregulin Sales Volume, by Type (2020-2031)
3.3.3 Global Human Neuregulin Sales Volume, by Type (%) (2020-2031)
3.4 Global Human Neuregulin Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Laboratory
4.1.2 University
4.1.3 Others
4.2 Global Human Neuregulin Sales Value by Application
4.2.1 Global Human Neuregulin Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Human Neuregulin Sales Value, by Application (2020-2031)
4.2.3 Global Human Neuregulin Sales Value, by Application (%) (2020-2031)
4.3 Global Human Neuregulin Sales Volume by Application
4.3.1 Global Human Neuregulin Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Human Neuregulin Sales Volume, by Application (2020-2031)
4.3.3 Global Human Neuregulin Sales Volume, by Application (%) (2020-2031)
4.4 Global Human Neuregulin Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Human Neuregulin Sales Value by Region
5.1.1 Global Human Neuregulin Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Human Neuregulin Sales Value by Region (2020-2025)
5.1.3 Global Human Neuregulin Sales Value by Region (2026-2031)
5.1.4 Global Human Neuregulin Sales Value by Region (%), (2020-2031)
5.2 Global Human Neuregulin Sales Volume by Region
5.2.1 Global Human Neuregulin Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Human Neuregulin Sales Volume by Region (2020-2025)
5.2.3 Global Human Neuregulin Sales Volume by Region (2026-2031)
5.2.4 Global Human Neuregulin Sales Volume by Region (%), (2020-2031)
5.3 Global Human Neuregulin Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Human Neuregulin Sales Value, 2020-2031
5.4.2 North America Human Neuregulin Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Human Neuregulin Sales Value, 2020-2031
5.5.2 Europe Human Neuregulin Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Human Neuregulin Sales Value, 2020-2031
5.6.2 Asia Pacific Human Neuregulin Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Human Neuregulin Sales Value, 2020-2031
5.7.2 South America Human Neuregulin Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Neuregulin Sales Value, 2020-2031
5.8.2 Middle East & Africa Human Neuregulin Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Neuregulin Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Human Neuregulin Sales Value and Sales Volume
6.2.1 Key Countries/Regions Human Neuregulin Sales Value, 2020-2031
6.2.2 Key Countries/Regions Human Neuregulin Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Human Neuregulin Sales Value, 2020-2031
6.3.2 United States Human Neuregulin Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Human Neuregulin Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Human Neuregulin Sales Value, 2020-2031
6.4.2 Europe Human Neuregulin Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Human Neuregulin Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Human Neuregulin Sales Value, 2020-2031
6.5.2 China Human Neuregulin Sales Value by Type (%), 2024 VS 2031
6.5.3 China Human Neuregulin Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Human Neuregulin Sales Value, 2020-2031
6.6.2 Japan Human Neuregulin Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Human Neuregulin Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Human Neuregulin Sales Value, 2020-2031
6.7.2 South Korea Human Neuregulin Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Human Neuregulin Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Human Neuregulin Sales Value, 2020-2031
6.8.2 Southeast Asia Human Neuregulin Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Human Neuregulin Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Human Neuregulin Sales Value, 2020-2031
6.9.2 India Human Neuregulin Sales Value by Type (%), 2024 VS 2031
6.9.3 India Human Neuregulin Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 BPS Bioscience
7.1.1 BPS Bioscience Company Information
7.1.2 BPS Bioscience Introduction and Business Overview
7.1.3 BPS Bioscience Human Neuregulin Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 BPS Bioscience Human Neuregulin Product Offerings
7.1.5 BPS Bioscience Recent Development
7.2 R&D Systems, Inc.
7.2.1 R&D Systems, Inc. Company Information
7.2.2 R&D Systems, Inc. Introduction and Business Overview
7.2.3 R&D Systems, Inc. Human Neuregulin Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 R&D Systems, Inc. Human Neuregulin Product Offerings
7.2.5 R&D Systems, Inc. Recent Development
7.3 YEASEN
7.3.1 YEASEN Company Information
7.3.2 YEASEN Introduction and Business Overview
7.3.3 YEASEN Human Neuregulin Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 YEASEN Human Neuregulin Product Offerings
7.3.5 YEASEN Recent Development
7.4 Sinobiological
7.4.1 Sinobiological Company Information
7.4.2 Sinobiological Introduction and Business Overview
7.4.3 Sinobiological Human Neuregulin Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Sinobiological Human Neuregulin Product Offerings
7.4.5 Sinobiological Recent Development
7.5 InVitria
7.5.1 InVitria Company Information
7.5.2 InVitria Introduction and Business Overview
7.5.3 InVitria Human Neuregulin Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 InVitria Human Neuregulin Product Offerings
7.5.5 InVitria Recent Development
7.6 Thermo Fisher Scientific Inc.
7.6.1 Thermo Fisher Scientific Inc. Company Information
7.6.2 Thermo Fisher Scientific Inc. Introduction and Business Overview
7.6.3 Thermo Fisher Scientific Inc. Human Neuregulin Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Thermo Fisher Scientific Inc. Human Neuregulin Product Offerings
7.6.5 Thermo Fisher Scientific Inc. Recent Development
7.7 Cell Guidance Systems LLC
7.7.1 Cell Guidance Systems LLC Company Information
7.7.2 Cell Guidance Systems LLC Introduction and Business Overview
7.7.3 Cell Guidance Systems LLC Human Neuregulin Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Cell Guidance Systems LLC Human Neuregulin Product Offerings
7.7.5 Cell Guidance Systems LLC Recent Development
7.8 Abcam Limited
7.8.1 Abcam Limited Company Information
7.8.2 Abcam Limited Introduction and Business Overview
7.8.3 Abcam Limited Human Neuregulin Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Abcam Limited Human Neuregulin Product Offerings
7.8.5 Abcam Limited Recent Development
7.9 ACROBiosystems
7.9.1 ACROBiosystems Company Information
7.9.2 ACROBiosystems Introduction and Business Overview
7.9.3 ACROBiosystems Human Neuregulin Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 ACROBiosystems Human Neuregulin Product Offerings
7.9.5 ACROBiosystems Recent Development
7.10 Proteintech Group, Inc
7.10.1 Proteintech Group, Inc Company Information
7.10.2 Proteintech Group, Inc Introduction and Business Overview
7.10.3 Proteintech Group, Inc Human Neuregulin Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Proteintech Group, Inc Human Neuregulin Product Offerings
7.10.5 Proteintech Group, Inc Recent Development
7.11 BioLegend, Inc
7.11.1 BioLegend, Inc Company Information
7.11.2 BioLegend, Inc Introduction and Business Overview
7.11.3 BioLegend, Inc Human Neuregulin Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 BioLegend, Inc Human Neuregulin Product Offerings
7.11.5 BioLegend, Inc Recent Development
8 Industry Chain Analysis
8.1 Human Neuregulin Industrial Chain
8.2 Human Neuregulin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Neuregulin Sales Model
8.5.2 Sales Channel
8.5.3 Human Neuregulin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Human Neuregulin Market Trends
Table 2. Human Neuregulin Market Drivers & Opportunity
Table 3. Human Neuregulin Market Challenges
Table 4. Human Neuregulin Market Restraints
Table 5. Global Human Neuregulin Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Human Neuregulin Revenue Market Share by Company (2020-2025)
Table 7. Global Human Neuregulin Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Human Neuregulin Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Human Neuregulin Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Human Neuregulin Manufacturing Base and Headquarters
Table 11. Key Manufacturers Human Neuregulin Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Human Neuregulin
Table 13. Global Human Neuregulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Neuregulin as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Neuregulin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Human Neuregulin Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Human Neuregulin Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Human Neuregulin Sales Market Share in Value by Type (2020-2025)
Table 20. Global Human Neuregulin Sales Market Share in Value by Type (2026-2031)
Table 21. Global Human Neuregulin Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Human Neuregulin Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Human Neuregulin Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Human Neuregulin Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Human Neuregulin Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Human Neuregulin Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Human Neuregulin Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Human Neuregulin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Human Neuregulin Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Human Neuregulin Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Human Neuregulin Sales Market Share in Value by Application (2020-2025)
Table 32. Global Human Neuregulin Sales Market Share in Value by Application (2026-2031)
Table 33. Global Human Neuregulin Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Human Neuregulin Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Human Neuregulin Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Human Neuregulin Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Human Neuregulin Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Human Neuregulin Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Human Neuregulin Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Human Neuregulin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Human Neuregulin Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Human Neuregulin Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Human Neuregulin Sales Value by Region (2020-2025) & (%)
Table 44. Global Human Neuregulin Sales Value by Region (2026-2031) & (%)
Table 45. Global Human Neuregulin Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Human Neuregulin Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Human Neuregulin Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Human Neuregulin Sales Volume by Region (2020-2025) & (%)
Table 49. Global Human Neuregulin Sales Volume by Region (2026-2031) & (%)
Table 50. Global Human Neuregulin Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Human Neuregulin Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Human Neuregulin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Human Neuregulin Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Human Neuregulin Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Human Neuregulin Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Human Neuregulin Sales Volume, (2026-2031) & (K Units)
Table 57. BPS Bioscience Company Information
Table 58. BPS Bioscience Introduction and Business Overview
Table 59. BPS Bioscience Human Neuregulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. BPS Bioscience Human Neuregulin Product Offerings
Table 61. BPS Bioscience Recent Development
Table 62. R&D Systems, Inc. Company Information
Table 63. R&D Systems, Inc. Introduction and Business Overview
Table 64. R&D Systems, Inc. Human Neuregulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. R&D Systems, Inc. Human Neuregulin Product Offerings
Table 66. R&D Systems, Inc. Recent Development
Table 67. YEASEN Company Information
Table 68. YEASEN Introduction and Business Overview
Table 69. YEASEN Human Neuregulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. YEASEN Human Neuregulin Product Offerings
Table 71. YEASEN Recent Development
Table 72. Sinobiological Company Information
Table 73. Sinobiological Introduction and Business Overview
Table 74. Sinobiological Human Neuregulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Sinobiological Human Neuregulin Product Offerings
Table 76. Sinobiological Recent Development
Table 77. InVitria Company Information
Table 78. InVitria Introduction and Business Overview
Table 79. InVitria Human Neuregulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. InVitria Human Neuregulin Product Offerings
Table 81. InVitria Recent Development
Table 82. Thermo Fisher Scientific Inc. Company Information
Table 83. Thermo Fisher Scientific Inc. Introduction and Business Overview
Table 84. Thermo Fisher Scientific Inc. Human Neuregulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Thermo Fisher Scientific Inc. Human Neuregulin Product Offerings
Table 86. Thermo Fisher Scientific Inc. Recent Development
Table 87. Cell Guidance Systems LLC Company Information
Table 88. Cell Guidance Systems LLC Introduction and Business Overview
Table 89. Cell Guidance Systems LLC Human Neuregulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Cell Guidance Systems LLC Human Neuregulin Product Offerings
Table 91. Cell Guidance Systems LLC Recent Development
Table 92. Abcam Limited Company Information
Table 93. Abcam Limited Introduction and Business Overview
Table 94. Abcam Limited Human Neuregulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Abcam Limited Human Neuregulin Product Offerings
Table 96. Abcam Limited Recent Development
Table 97. ACROBiosystems Company Information
Table 98. ACROBiosystems Introduction and Business Overview
Table 99. ACROBiosystems Human Neuregulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. ACROBiosystems Human Neuregulin Product Offerings
Table 101. ACROBiosystems Recent Development
Table 102. Proteintech Group, Inc Company Information
Table 103. Proteintech Group, Inc Introduction and Business Overview
Table 104. Proteintech Group, Inc Human Neuregulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Proteintech Group, Inc Human Neuregulin Product Offerings
Table 106. Proteintech Group, Inc Recent Development
Table 107. BioLegend, Inc Company Information
Table 108. BioLegend, Inc Introduction and Business Overview
Table 109. BioLegend, Inc Human Neuregulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. BioLegend, Inc Human Neuregulin Product Offerings
Table 111. BioLegend, Inc Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Human Neuregulin Downstream Customers
Table 115. Human Neuregulin Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Neuregulin Product Picture
Figure 2. Global Human Neuregulin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Human Neuregulin Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Human Neuregulin Sales Volume (2020-2031) & (K Units)
Figure 5. Global Human Neuregulin Sales Price (2020-2031) & (US$/Unit)
Figure 6. Human Neuregulin Report Years Considered
Figure 7. Global Human Neuregulin Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Human Neuregulin Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Neuregulin Revenue in 2024
Figure 10. Human Neuregulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Purity < 97% Picture
Figure 12. Purity ≥ 97% Picture
Figure 13. Global Human Neuregulin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Human Neuregulin Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Human Neuregulin Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 16. Global Human Neuregulin Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Human Neuregulin Price by Type (2020-2031) & (US$/Unit)
Figure 18. Product Picture of Laboratory
Figure 19. Product Picture of University
Figure 20. Product Picture of Others
Figure 21. Global Human Neuregulin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Human Neuregulin Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global Human Neuregulin Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 24. Global Human Neuregulin Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global Human Neuregulin Price by Application (2020-2031) & (US$/Unit)
Figure 26. North America Human Neuregulin Sales Value (2020-2031) & (US$ Million)
Figure 27. North America Human Neuregulin Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe Human Neuregulin Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe Human Neuregulin Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific Human Neuregulin Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Human Neuregulin Sales Value by Region (%), 2024 VS 2031
Figure 32. South America Human Neuregulin Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America Human Neuregulin Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa Human Neuregulin Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa Human Neuregulin Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions Human Neuregulin Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions Human Neuregulin Sales Volume (%), (2020-2031)
Figure 38. United States Human Neuregulin Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States Human Neuregulin Sales Value by Type (%), 2024 VS 2031
Figure 40. United States Human Neuregulin Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe Human Neuregulin Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe Human Neuregulin Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe Human Neuregulin Sales Value by Application (%), 2024 VS 2031
Figure 44. China Human Neuregulin Sales Value, (2020-2031) & (US$ Million)
Figure 45. China Human Neuregulin Sales Value by Type (%), 2024 VS 2031
Figure 46. China Human Neuregulin Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan Human Neuregulin Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan Human Neuregulin Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan Human Neuregulin Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea Human Neuregulin Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea Human Neuregulin Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea Human Neuregulin Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia Human Neuregulin Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia Human Neuregulin Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia Human Neuregulin Sales Value by Application (%), 2024 VS 2031
Figure 56. India Human Neuregulin Sales Value, (2020-2031) & (US$ Million)
Figure 57. India Human Neuregulin Sales Value by Type (%), 2024 VS 2031
Figure 58. India Human Neuregulin Sales Value by Application (%), 2024 VS 2031
Figure 59. Human Neuregulin Industrial Chain
Figure 60. Human Neuregulin Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Human Neuregulin in 2025?
The global market size of Human Neuregulin in 2025 was 231 Million USD.
Which companies rank high in the global Human Neuregulin market?
Which region is expected to have the highest market share?
What was the global market size of Human Neuregulin in 2031?
What is the annual compound growth rate of the global Human Neuregulin market size from 2025 to 2031?
Related Reports
Global Human Neuregulin Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Human Neuregulin market is projected to grow from US$ 231 million in 2025 to US$ 323 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 168
USD 4900.00
(Single User License)
Global Human Neuregulin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Neuregulin market size was US$ 231 million in 2025 and is forecast to reach a readjusted size of US$ 323 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 91
USD 4250.00
(Single User License)
Global Human Neuregulin Market Research Report 2026
The global Human Neuregulin market was valued at US$ 231 million in 2025 and is anticipated to reach US$ 323 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 118
USD 2900.00
(Single User License)
Human Neuregulin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Neuregulin was estimated to be worth US$ 231 million in 2025 and is projected to reach US$ 323 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 124
USD 3950.00
(Single User License)
Global Human Neuregulin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Neuregulin market size was US$ 221 million in 2024 and is forecast to a readjusted size of US$ 309 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 98
USD 4250.00
(Single User License)
Global Human Neuregulin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Neuregulin market is projected to grow from US$ 221 million in 2024 to US$ 309 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 154
USD 4900.00
(Single User License)
Global Human Neuregulin Market Research Report 2025
The global market for Human Neuregulin was valued at US$ 221 million in the year 2024 and is projected to reach a revised size of US$ 309 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-03-10
Pages: 93
USD 2900.00
(Single User License)
Global Human Neuregulin Market Insights, Forecast to 2030
The global Human Neuregulin market is projected to grow from US$ 221 million in 2024 to US$ 296 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period.
Published Date: 2024-11-15
Pages: 161
USD 4900.00
(Single User License)
Global and United States Human Neuregulin Market Report & Forecast 2024-2030
The global Human Neuregulin revenue was US$ 208 million in 2023 and is forecast to a readjusted size of US$ 296 million by 2030 with a CAGR of 5.0% during the review period (2024-2030).
Published Date: 2024-11-15
Pages: 131
USD 4350.00
(Single User License)
Human Neuregulin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Human Neuregulin was estimated to be worth US$ 208 million in 2023 and is forecast to a readjusted size of US$ 296 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published Date: 2024-11-15
Pages: 114
USD 3950.00
(Single User License)
Global Human Neuregulin Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Human Neuregulin market is projected to grow from US$ 231 million in 2025 to US$ 323 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 168
USD 4900.00 (Single User License)Global Human Neuregulin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Neuregulin market size was US$ 231 million in 2025 and is forecast to reach a readjusted size of US$ 323 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 91
USD 4250.00 (Single User License)Global Human Neuregulin Market Research Report 2026
The global Human Neuregulin market was valued at US$ 231 million in 2025 and is anticipated to reach US$ 323 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 118
USD 2900.00 (Single User License)Human Neuregulin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Neuregulin was estimated to be worth US$ 231 million in 2025 and is projected to reach US$ 323 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 124
USD 3950.00 (Single User License)Global Human Neuregulin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Neuregulin market size was US$ 221 million in 2024 and is forecast to a readjusted size of US$ 309 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 98
USD 4250.00 (Single User License)Global Human Neuregulin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Neuregulin market is projected to grow from US$ 221 million in 2024 to US$ 309 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 154
USD 4900.00 (Single User License)Global Human Neuregulin Market Research Report 2025
The global market for Human Neuregulin was valued at US$ 221 million in the year 2024 and is projected to reach a revised size of US$ 309 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-03-10
Pages: 93
USD 2900.00 (Single User License)Global Human Neuregulin Market Insights, Forecast to 2030
The global Human Neuregulin market is projected to grow from US$ 221 million in 2024 to US$ 296 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period.
Published: 2024-11-15
Pages: 161
USD 4900.00 (Single User License)Global and United States Human Neuregulin Market Report & Forecast 2024-2030
The global Human Neuregulin revenue was US$ 208 million in 2023 and is forecast to a readjusted size of US$ 296 million by 2030 with a CAGR of 5.0% during the review period (2024-2030).
Published: 2024-11-15
Pages: 131
USD 4350.00 (Single User License)Human Neuregulin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Human Neuregulin was estimated to be worth US$ 208 million in 2023 and is forecast to a readjusted size of US$ 296 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published: 2024-11-15
Pages: 114
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now